Related references
Note: Only part of the references are listed.Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells
Jeong-Ran Park et al.
JOURNAL OF HEPATOLOGY (2011)
Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer
Ran-Ju Kim et al.
CANCER LETTERS (2010)
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide
Xiaofei Wang et al.
CANCER SCIENCE (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer
Y. Rebecca Chin et al.
CELLULAR SIGNALLING (2009)
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
Satoshi Nakayama et al.
BREAST CANCER RESEARCH (2009)
Dysadherin: A new, player in cancer progression
Jeong-Seok Nam et al.
CANCER LETTERS (2007)
Roles of AKT signal in breast cancer
Wen Liu et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells
Jeong-Seok Nam et al.
CANCER RESEARCH (2006)
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor β in a mouse model of breast cancer
Jeong-Seok Nam et al.
CANCER RESEARCH (2006)
Deciphering cellular states of innate tumor drug responses
E Graudens et al.
GENOME BIOLOGY (2006)
The transcriptional repressor snail promotes mammary tumor recurrence
SE Moody et al.
CANCER CELL (2005)
Regulation of cancer cell motility through actin reorganization
D Yamazaki et al.
CANCER SCIENCE (2005)
NF-kB in development and progression of human cancer
X Dolcet et al.
VIRCHOWS ARCHIV (2005)
Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility
SP Barwe et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Epithelial-mesenchymal transitions:: Twist in development and metastasis
YB Kang et al.
CELL (2004)
5-Aza-2 '-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis
JS Nam et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis
LB Eckert et al.
CANCER RESEARCH (2004)
Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells
T Shimamura et al.
CANCER RESEARCH (2004)
Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion
H Tsuiji et al.
GLYCOBIOLOGY (2003)
Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: Relationship to E-cadherin expression
T Shimamura et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj et al.
ONCOGENE (2003)
The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras
C Jiménez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
G Pérez-Tenorio et al.
BRITISH JOURNAL OF CANCER (2002)
Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis
Y Ino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of protein kinase C in the signal pathways that link Na+/K+-ATPase to ERK1/2
K Mohammadi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
M Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)